Sensitivity of salivary glands to radiation: from animal models to therapies
- PMID: 19783796
- PMCID: PMC2882712
- DOI: 10.1177/0022034509343143
Sensitivity of salivary glands to radiation: from animal models to therapies
Abstract
Radiation therapy for head and neck cancer causes significant secondary side-effects in normal salivary glands, resulting in diminished quality of life for these individuals. Salivary glands are exquisitely sensitive to radiation and display acute and chronic responses to radiotherapy. This review will discuss clinical implications of radiosensitivity in normal salivary glands, compare animal models used to investigate radiation-induced salivary gland damage, address therapeutic advances, and project future directions in the field.
Figures
Similar articles
-
Radiotherapy-induced salivary dysfunction: Structural changes, pathogenetic mechanisms and therapies.Arch Oral Biol. 2015 Dec;60(12):1802-10. doi: 10.1016/j.archoralbio.2015.09.014. Epub 2015 Sep 25. Arch Oral Biol. 2015. PMID: 26454716 Review.
-
Pathophysiology and management of radiation-induced xerostomia.J Support Oncol. 2005 May-Jun;3(3):191-200. J Support Oncol. 2005. PMID: 15915820 Review.
-
Natural history and prevention of radiation injury.Adv Dent Res. 2000 Dec;14:57-61. doi: 10.1177/08959374000140010901. Adv Dent Res. 2000. PMID: 11842925 Review.
-
[Current status of prevention and management of radiation-induced xerostomia].Zhonghua Kou Qiang Yi Xue Za Zhi. 2010 Feb;45(2):121-3. Zhonghua Kou Qiang Yi Xue Za Zhi. 2010. PMID: 20368009 Review. Chinese. No abstract available.
-
Radioactive iodine and the salivary glands.Thyroid. 2003 Mar;13(3):265-71. doi: 10.1089/105072503321582060. Thyroid. 2003. PMID: 12729475 Review.
Cited by
-
Increased Expression of TGF-β Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation.PLoS One. 2015 May 8;10(5):e0123641. doi: 10.1371/journal.pone.0123641. eCollection 2015. PLoS One. 2015. PMID: 25955532 Free PMC article.
-
Estimating Thyroid Doses From Modified Barium Swallow Studies.Health Phys. 2018 Sep;115(3):360-368. doi: 10.1097/HP.0000000000000890. Health Phys. 2018. PMID: 30045116 Free PMC article.
-
Current State of Knowledge on Salivary Gland Cancers.Crit Rev Oncog. 2018;23(3-4):139-151. doi: 10.1615/CritRevOncog.2018027598. Crit Rev Oncog. 2018. PMID: 30311570 Free PMC article. Review.
-
P2 Receptors as Therapeutic Targets in the Salivary Gland: From Physiology to Dysfunction.Front Pharmacol. 2020 Mar 13;11:222. doi: 10.3389/fphar.2020.00222. eCollection 2020. Front Pharmacol. 2020. PMID: 32231563 Free PMC article. Review.
-
RGDSP-Decorated Hyaluronate Hydrogels Facilitate Rapid 3D Expansion of Amylase-Expressing Salivary Gland Progenitor Cells.ACS Biomater Sci Eng. 2021 Dec 13;7(12):5749-5761. doi: 10.1021/acsbiomaterials.1c00745. Epub 2021 Nov 15. ACS Biomater Sci Eng. 2021. PMID: 34781679 Free PMC article.
References
-
- Anne PR. (2002). Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer. Semin Oncol 29(6 Suppl 19):80-83; erratum in Semin Oncol 30:417, 2003 - PubMed
-
- Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. (2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756-760 - PubMed
-
- Baum BJ, Zheng C, Cotrim AP, Goldsmith CM, Atkinson JC, Brahim JS, et al. (2006). Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta 1758:1071-1077 - PubMed
-
- Braam PM, Terhaard CH, Roesink JM, Raaijmakers CP. (2006). Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 66:975-980 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R03 DE017918-01A1/DE/NIDCR NIH HHS/United States
- R01 DE018888-01A1/DE/NIDCR NIH HHS/United States
- P30 CA023074/CA/NCI NIH HHS/United States
- R03 DE017918,/DE/NIDCR NIH HHS/United States
- R01 DE18888/DE/NIDCR NIH HHS/United States
- T32 CA09213-30/CA/NCI NIH HHS/United States
- K22 DE016096/DE/NIDCR NIH HHS/United States
- R03 DE017918/DE/NIDCR NIH HHS/United States
- K22 DE016096-01A1/DE/NIDCR NIH HHS/United States
- K22 DE16096/DE/NIDCR NIH HHS/United States
- T32 CA009213/CA/NCI NIH HHS/United States
- R01 DE018888/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical